1. Home
  2. NTST vs COGT Comparison

NTST vs COGT Comparison

Compare NTST & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTST
  • COGT
  • Stock Information
  • Founded
  • NTST 2019
  • COGT 2014
  • Country
  • NTST United States
  • COGT United States
  • Employees
  • NTST N/A
  • COGT N/A
  • Industry
  • NTST Real Estate Investment Trusts
  • COGT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTST Real Estate
  • COGT Health Care
  • Exchange
  • NTST Nasdaq
  • COGT Nasdaq
  • Market Cap
  • NTST 1.3B
  • COGT 1.1B
  • IPO Year
  • NTST 2020
  • COGT 2018
  • Fundamental
  • Price
  • NTST $18.19
  • COGT $12.45
  • Analyst Decision
  • NTST Strong Buy
  • COGT Strong Buy
  • Analyst Count
  • NTST 9
  • COGT 11
  • Target Price
  • NTST $19.58
  • COGT $21.20
  • AVG Volume (30 Days)
  • NTST 1.0M
  • COGT 1.5M
  • Earning Date
  • NTST 11-03-2025
  • COGT 11-11-2025
  • Dividend Yield
  • NTST 4.71%
  • COGT N/A
  • EPS Growth
  • NTST N/A
  • COGT N/A
  • EPS
  • NTST N/A
  • COGT N/A
  • Revenue
  • NTST $179,740,000.00
  • COGT N/A
  • Revenue This Year
  • NTST $15.57
  • COGT N/A
  • Revenue Next Year
  • NTST $5.72
  • COGT N/A
  • P/E Ratio
  • NTST N/A
  • COGT N/A
  • Revenue Growth
  • NTST 21.39
  • COGT N/A
  • 52 Week Low
  • NTST $13.42
  • COGT $3.72
  • 52 Week High
  • NTST $19.18
  • COGT $13.50
  • Technical
  • Relative Strength Index (RSI)
  • NTST 48.67
  • COGT 55.51
  • Support Level
  • NTST $17.53
  • COGT $12.50
  • Resistance Level
  • NTST $18.43
  • COGT $13.50
  • Average True Range (ATR)
  • NTST 0.34
  • COGT 0.53
  • MACD
  • NTST -0.03
  • COGT -0.03
  • Stochastic Oscillator
  • NTST 52.10
  • COGT 41.62

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: